EMA — authorised 20 February 2014
- Status: approved
EMA authorised Vemlidy on 20 February 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 20 February 2014.
Gilead Sciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.